Injective Introduces Pre-IPO Market for Anthropic Before Nasdaq Launch
Injective has launched a pre-IPO market for Anthropic, providing investors with early access to the AI company's equity ahead of its public debut on Nasdaq. Anthropic is set to launch its initial public offering on November 19, 2026, with plans to offer 825 million shares priced between $70 and $78, which could lead to a valuation ranging from $1.25 trillion to $1.45 trillion.
The establishment of the pre-IPO market on Injective indicates strong interest in Anthropic's upcoming market entry. Investors are keenly observing the IPO as it is expected to gauge public interest in AI sector investments, especially since Anthropic was last privately valued at approximately $965 billion. This move by Injective reflects confidence in Anthropic's valuation and the timing of its market entry, as evidenced by current market pricing and activity.
For Your Trading Desk
Sponsor Spike Success.
Current market data shows robust support for the November 19 IPO date, with a 93.3% YES pricing, while earlier dates have minimal backing. Predictions regarding Anthropic's market capitalization at the close of the IPO suggest that investors expect a valuation within the proposed range, with a 43.5% chance of achieving a market cap between $1.25 trillion and $1.5 trillion.
Regulatory Scrutiny and Market Sentiment Surround Anthropic's IPO
Attention will be focused on regulatory approvals, particularly the SEC's review of Anthropic's registration statement, which is crucial for confirming the November 19 date. Market participants will also keep an eye on underwriter reports and any potential adjustments to the IPO pricing or size, as these factors could significantly influence market sentiment. Additionally, developments in the broader AI sector or shifts in market conditions may impact Anthropic's valuation and investor interest leading up to the IPO.




